Urethral Stricture Treatment Devices Market to Grow at a Significant CAGR of 7.10% by 2026, Examines DelveInsight

Urethral Stricture Treatment Devices Market

DelveInsight’s “Urethral Stricture Treatment Devices Market Insights, Competitive Landscape and Market Forecast–2026” report delivers an in-depth understanding of the Bone Densitometers, historical and forecasted epidemiology as well as the Bone Densitometers market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

 

Some facts of  Urethral Stricture Treatment Device Market

According to DelveInsight, the global urethral stricture treatment devices market will increase at a CAGR of 7.10 percent during the forecasted period from 2021 to 2026, to reach USD 2.08 billion by 2026. 
As per the statistics quoted by the World Health Organization in their Decade of Healthy Ageing (2020–2030) Report, it has been estimated that people in the age bracket of 60 years and older will account for 34% more share in the total population, increasing from one billion in 2019 to 1.4 billion by 2030.
Urotronic received regulatory approval from the US Food and Drug Administration in December 2021 for their product, Optilume, a drug-coated urology balloon that elutes paclitaxel, a highly lipophilic drug that limits hyperactive cell proliferation and the formation of fibrotic scar tissue, which results in stricture recurrence.
As per the data cited by the World Health Organization (WHO), in 2020, cancer of the colon and rectum were the third-most common cancer type globally and accounted for 1.93 million new cases.

 

For more insights into Urethral Stricture Treatment Devices, get the snapshot of the key highlights entailed in the Urethral Stricture Treatment Devices Market

 

Urethral Stricture Treatment Devices Overview

A urethral stricture is caused by scarring that narrows the tube that drains urines from your body (urethra). A stricture inhibits the passage of urine from the bladder and can result in a range of urinary tract medical concerns, such as irritation or infection. Males are more likely to suffer from urethral stricture. 

Symptoms of urethral stricture includes: 

Decrease in urine flow
Incomplete bladder emptying
Urine stream sprinkling 
Difficulty, straining, or discomfort when urinating
Frequent urge to urinate 
Infection of the urinary tract

 

 

Geography Wise- Urethral Stricture Treatment Devices Market Analysis

The Urethral Stricture Treatment Devices market is analyzed geographically for North America, Europe, Asia-Pacific, and the Rest of the World. North America is predicted to account for the highest part of the Global urethral stricture treatment devices market. This dominance is due to an increase in the prevalence of cancer in the region. Furthermore, the expanding senior population, as well as rising obesity rates in the United States, are likely to result in an increase in the frequency of urethral strictures in the North American area. Furthermore, strong product development research and development efforts, as well as a favorable regulatory environment, assist product producers in generating more income from the region.

 

To know why North America is leading the market growth in Urethral Stricture Treatment Devices market, get a snapshot of the Urethral Stricture Treatment Landscape

 

Furthermore, according to CDC statistics (2021), the obesity prevalence in the country was 42.4 percent in 2017-2018. Obesity has been linked to an increased mean urethral stricture length in obese people compared to patients with a normal BMI. 

As a result, the interaction of all the aforementioned factors is expected to boost the market expansion of urethral stricture treatment devices in the United States during the forecast period.

During the forecast period, the urethral balloon dilation catheters product segment is likely to exhibit a healthy CAGR in the urethral stricture treatment devices market. This can be ascribed to the benefits that these devices have over their competitors. Balloon dilation is a safe, well-tolerated office-based treatment that has several benefits over sequential rigid dilation and internal urethrotomy. It is connected with a low risk of problems. Furthermore, urethral balloon dilation is seen as a minimally invasive method with the potential benefit of being less morbid and technically less difficult to do. It is also said to be less painful than sequential rigid dilatation.

Because of the benefits associated with urethral balloon dilation catheters, there has been an increase in the development of newer products aimed at treating urethral strictures, and product development innovation is expected to boost demand for this product category, ultimately propelling the market for urethral balloon dilation catheters during the forecast period.

 

Urethral Stricture Treatment Devices Market Scope

Study Period: 2021-2026

Key Urethral Stricture Devices Companies: Boston Scientific Corporation, Laborie, Cook, Teleflex Incorporated, B. Braun Melsungen AG, Allium Ltd., Pnn Medical A/S, Zhejiang ChuangXiang Medical Technology co., LTH, UROMED Kurt Drews KG, Med pro Medical B.V., BD, Cardinal Health, Coloplast, ConvaTec Inc, BACTIGUARD ABand others.

Market Segment Analysis By Product Type: Urethral Dilators, Urethral Stents, Urethral Balloon Dilation Catheters, And Urinary Catheters

Market Segment Analysis By Stricture Location: Anterior and Posterior

Market Segment Analysis By End User: Hospitals, Specialty Clinics, and Others

Geography Covered: North America, Europe, Asia- Pacific, Rest of the World (Middle East, Africa, and South America)

 

Table of Contents

Urethral Stricture Treatment Devices Market Report Introduction
Urethral Stricture Treatment Devices  Market Executive Summary
Regulatory Analysis
Urethral Stricture Treatment Devices Market Key Factors Analysis
Urethral Stricture Treatment Devices Market Porter’s Five Forces Analysis
COVID-19 Impact Analysis on Urethral Stricture Treatment Devices Market
Urethral Stricture Treatment Devices Market Layout
Urethral Stricture Treatment Devices Market Company and Product Profiles
 KOL Views
PROJECT APPROACH
About DelveInsight
Disclaimer & Contact Us

 

About DelveInsight

DelveInsight is a leading Business Consultant, and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance. It also offers Healthcare Consulting Services, which benefits in market analysis to accelerate the business growth and overcome challenges with a practical approach.

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Ankit Nigam
Email: Send Email
Phone: +19193216187
Address:304 S. Jones Blvd #2432
City: Albany
State: New York
Country: United States
Website: https://www.delveinsight.com/report-store/urethral-stricture-treatment-devices-market